Ben R. Taylor, CFO: Recursion Pharmaceuticals RXRX Sell · Filed 02/19

Trade details

Type: Insider sale
Amount: $41,352.08
Shares · price: 13,426 sh · $3.08 a share
Held after: 1,195,349 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Ben R. TaylorCFO
Trade date: 26/02/18
Filed: 26/02/19
Days to filing: 1 days

Sold 1.1% of holdings

Share of holding sold: 1.1%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Ben R. Taylor's recent trades

Ben R. TaylorCFO
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$27K
7,956 sh
$27K
Filed 03/18
Traded 03/17
Ben R. TaylorCFO
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$27K
7,956 sh
$27K
Filed 03/17
Traded 03/17
Ben R. TaylorCFO
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$41.4K
13,426 sh
$41.4K
Filed 02/18
Traded 02/18
Ben R. TaylorCFO
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$89.4K
21,383 sh
$89.4K
Filed 25/12/30
Traded 25/12/29
Ben R. TaylorCFO
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$89.4K
21,383 sh
$89.4K
Filed 25/12/29
Traded 25/12/29

Ben R. Taylor, CFO — sold $41.4K of Recursion Pharmaceuticals RXRX · 1.1% of holdings · 10b5-1 plan | Whalegun